Welcome to our dedicated page for PMGC Holdings news (Ticker: elab), a resource for investors and traders seeking the latest updates and insights on PMGC Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PMGC Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PMGC Holdings's position in the market.
NorthStrive Biosciences (Nasdaq: ELAB) filed U.S. Patent Application No. 19/655,160 to expand its EL-22 myostatin-engineered probiotic into human pharmaceutical uses.
The application covers formulated pharmaceutical products, specific dosing regimens and formulations for a broad range of muscle-wasting conditions including sarcopenia, disuse atrophy and certain neurological disorders, and notes potential use alongside GLP-1 weight-loss treatments. The filing aims to strengthen NorthStrive's intellectual property portfolio for muscle-preservation therapeutics.
NorthStrive Defense Tech (NASDAQ: ELAB) announced on April 23, 2026 an exclusive option agreement to license U.S. Patent No. 12,277,716 B2, a patented visual-inertial cooperative navigation system for drones operating in GPS-jammed, spoofed, and denied environments.
The option covers exclusive patent rights in the aerospace and defense field plus a non-exclusive know-how license; the company will evaluate the technology during a defined period and may negotiate a definitive license if it exercises the option. No guarantee of a final license or successful commercialization was given.
PMGC Holdings (Nasdaq: ELAB) subsidiary SVM Machining signed a Long-Term Agreement with Turbo-Jet Products to supply mission-critical aerospace and defense components.
The LTA has an initial five-year term with annual renewal provisions, forms a purchasing framework for future orders, and follows SVM's ITAR registration on March 20, 2026.
PMGC Holdings (Nasdaq: ELAB) announced a $40 million equity purchase facility with an institutional investor on April 17, 2026, with approximately $10 million expected at first closing. The facility provides a 24-month commitment period and permits draws at PMGC's discretion, supporting an accelerated M&A roll-up focused on aerospace, defense, and industrial precision manufacturing.
PMGC has completed four acquisitions over the past 12 months and targets ITAR-registered, AS9100D-certified precision CNC machining businesses, plus opportunistic cash-flow positive targets outside aerospace and defense.
NorthStrive Biosciences (NASDAQ: ELAB) announced on April 13, 2026 the U.S. transfer of its EL-32 Working Cell Bank (WCB) to a third-party fermentation facility and the start of a manufacturing optimization program to raise yield and enable scalable, cost-efficient production.
EL-32 is a dual-action engineered probiotic targeting myostatin and activin-A pathways to help preserve lean muscle during GLP-1 therapy. Collaboration with Modulant Biosciences covers process development for animal-health products while NorthStrive retains human therapeutic rights, aiming to support IND-enabling activities and future GMP manufacturing.
Pacific Sun Packaging (NASDAQ: ELAB) will exhibit at ITAD Europe 2026 on April 15–16, 2026 in Nice, France, marking an expansion of its international presence.
The company will present protective packaging for high-value IT hardware at Booth #414, targeting global buyers, recyclers, and enterprise decision-makers across the ITAD and circular electronics supply chain.
AGA Precision Systems (Nasdaq: ELAB) executed a second long-term agreement on April 9, 2026, with a globally recognized Tier 1 aerospace and defense customer to supply precision CNC-manufactured components for multi-year programs. The LTA formalizes future purchase orders and includes defined performance commitments for quality, delivery, and pricing.
AGA said the agreement reinforces its qualified-supplier status, supports recurring revenue potential, and increases operational visibility while the customer identity remains confidential due to ITAR and regulatory obligations.
PMGC Holdings (NASDAQ: ELAB) has fully utilized a $20.0 million equity purchase facility with Streeterville Capital, strengthening cash to fund near-term acquisitions.
PMGC closed four precision manufacturing and specialty packaging acquisitions from July 2025–February 2026 and advances Northstrive Biosciences' EL-22 toward a Phase 2 IND pathway.
NorthStrive Defense Tech (NASDAQ: ELAB) acquired an exclusive option to license U.S. Patent No. 12,291,334 for a multi-domain drone system that transports cable-suspended payloads through water while flying above the surface. Key capabilities include buoyancy-assisted payload efficiency, trajectory optimization, and operation in coastal, riverine, and flood-prone areas.
The Option Agreement allows development and financing during the Option Period; exercise would trigger negotiation of a definitive license to commercialize the technology. No guarantee of a final license or commercialization is provided.
PMGC Holdings (NASDAQ: ELAB) announced the formation of a wholly owned subsidiary, NorthStrive Defense Tech LLC, to target defense technology with emphasis on drones, autonomous systems, and unmanned defense solutions.
The subsidiary will pursue acquisitions, licensing, and partnerships and plans to leverage PMGC's existing operating subsidiaries, AGA Precision Systems and Silicon Valley Machining, to accelerate commercialization. The company warned there is no assurance these efforts will generate revenue or operational success and said a follow-up announcement is planned.